S&P 500   3,791.49 (-1.51%)
DOW   30,569.97 (-1.19%)
QQQ   323.60 (-1.52%)
AAPL   143.19 (+0.02%)
MSFT   234.83 (+1.08%)
FB   276.04 (-2.13%)
GOOGL   1,840.52 (-3.53%)
AMZN   3,278.09 (-1.44%)
TSLA   881.25 (-0.21%)
NVDA   520.71 (-3.11%)
BABA   262.83 (-1.16%)
CGC   38.92 (+9.57%)
GE   10.82 (-4.16%)
MU   76.60 (-3.66%)
AMD   90.88 (-4.04%)
NIO   58.47 (-3.05%)
T   29.42 (-1.11%)
F   10.86 (-2.95%)
ACB   11.61 (+8.81%)
BA   194.40 (-3.79%)
DIS   164.54 (-2.96%)
NFLX   538.58 (-4.16%)
GILD   65.58 (-1.68%)
S&P 500   3,791.49 (-1.51%)
DOW   30,569.97 (-1.19%)
QQQ   323.60 (-1.52%)
AAPL   143.19 (+0.02%)
MSFT   234.83 (+1.08%)
FB   276.04 (-2.13%)
GOOGL   1,840.52 (-3.53%)
AMZN   3,278.09 (-1.44%)
TSLA   881.25 (-0.21%)
NVDA   520.71 (-3.11%)
BABA   262.83 (-1.16%)
CGC   38.92 (+9.57%)
GE   10.82 (-4.16%)
MU   76.60 (-3.66%)
AMD   90.88 (-4.04%)
NIO   58.47 (-3.05%)
T   29.42 (-1.11%)
F   10.86 (-2.95%)
ACB   11.61 (+8.81%)
BA   194.40 (-3.79%)
DIS   164.54 (-2.96%)
NFLX   538.58 (-4.16%)
GILD   65.58 (-1.68%)
S&P 500   3,791.49 (-1.51%)
DOW   30,569.97 (-1.19%)
QQQ   323.60 (-1.52%)
AAPL   143.19 (+0.02%)
MSFT   234.83 (+1.08%)
FB   276.04 (-2.13%)
GOOGL   1,840.52 (-3.53%)
AMZN   3,278.09 (-1.44%)
TSLA   881.25 (-0.21%)
NVDA   520.71 (-3.11%)
BABA   262.83 (-1.16%)
CGC   38.92 (+9.57%)
GE   10.82 (-4.16%)
MU   76.60 (-3.66%)
AMD   90.88 (-4.04%)
NIO   58.47 (-3.05%)
T   29.42 (-1.11%)
F   10.86 (-2.95%)
ACB   11.61 (+8.81%)
BA   194.40 (-3.79%)
DIS   164.54 (-2.96%)
NFLX   538.58 (-4.16%)
GILD   65.58 (-1.68%)
S&P 500   3,791.49 (-1.51%)
DOW   30,569.97 (-1.19%)
QQQ   323.60 (-1.52%)
AAPL   143.19 (+0.02%)
MSFT   234.83 (+1.08%)
FB   276.04 (-2.13%)
GOOGL   1,840.52 (-3.53%)
AMZN   3,278.09 (-1.44%)
TSLA   881.25 (-0.21%)
NVDA   520.71 (-3.11%)
BABA   262.83 (-1.16%)
CGC   38.92 (+9.57%)
GE   10.82 (-4.16%)
MU   76.60 (-3.66%)
AMD   90.88 (-4.04%)
NIO   58.47 (-3.05%)
T   29.42 (-1.11%)
F   10.86 (-2.95%)
ACB   11.61 (+8.81%)
BA   194.40 (-3.79%)
DIS   164.54 (-2.96%)
NFLX   538.58 (-4.16%)
GILD   65.58 (-1.68%)
Log in
NYSEARCA:XDIV

Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 Stock Forecast, Price & News

$85.42
+0.14 (+0.16 %)
(As of 01/27/2021 07:10 AM ET)
Add
Today's Range
$85.42
Now: $85.42▼
$85.42
50-Day Range
$79.45
MA: $83.24▼
$88.14
52-Week Range
$45.76
Now: $85.42▼
$88.14
Volume7 shs
Average Volume2,263 shs
Market Capitalization$34.17 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Geographic Exposure of XDIV


Basic Details

Issuer Metaurus Advisors
Fund NameUS Equity EX Dividend Fund-Series 2027
Tax ClassificationPartnership
SymbolNYSEARCA:XDIV
Inception Date2/15/2018
Fund ManagerRichard Sandulli, Jamie Greenwald, Donald M. Callahan, Sean A. Dillon
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkSolactive US Ex-Dividends Index Series 2027
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$30.27 million
Average Daily Volume$51.70
Discount/Premium-0.38%

ETF Expenses

Management Fee0.29%
Other Expenses0.27%
Total Expenses0.56%
Fee Waiver0.00%
Net Expenses0.56%

Administrator, Advisor and Custodian

AdministratorSEI Investments Global Fund Services
AdvisorMetaurus Advisors LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
TrusteeWilmington Trust Company
Lead Market MakerVirtu Financial
$85.42
+0.14 (+0.16 %)
(As of 01/27/2021 07:10 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XDIV News and Ratings via Email

Sign-up to receive the latest news and ratings for XDIV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (NYSEARCA:XDIV) Frequently Asked Questions

How has Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's stock been impacted by COVID-19 (Coronavirus)?

Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's stock was trading at $57.41 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, XDIV shares have increased by 48.8% and is now trading at $85.42.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Metaurus U.S. Equity Ex-Dividend Fund-Series 2027?

Wall Street analysts have given Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's stock symbol?

Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XDIV."

How do I buy shares of Metaurus U.S. Equity Ex-Dividend Fund-Series 2027?

Shares of XDIV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's stock price today?

One share of XDIV stock can currently be purchased for approximately $85.42.

How big of a company is Metaurus U.S. Equity Ex-Dividend Fund-Series 2027?

Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 has a market capitalization of $34.17 million.

This page was last updated on 1/27/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.